Matches in Wikidata for { <http://www.wikidata.org/entity/Q66067477> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q66067477 description "clinical trial" @default.
- Q66067477 description "ensayu clínicu" @default.
- Q66067477 description "klinisch onderzoek" @default.
- Q66067477 description "клінічне випробування" @default.
- Q66067477 name "Olaparib and High-Dose Chemotherapy in Treating Participants With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant" @default.
- Q66067477 name "Olaparib and High-Dose Chemotherapy in Treating Participants With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant" @default.
- Q66067477 type Item @default.
- Q66067477 label "Olaparib and High-Dose Chemotherapy in Treating Participants With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant" @default.
- Q66067477 label "Olaparib and High-Dose Chemotherapy in Treating Participants With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant" @default.
- Q66067477 prefLabel "Olaparib and High-Dose Chemotherapy in Treating Participants With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant" @default.
- Q66067477 prefLabel "Olaparib and High-Dose Chemotherapy in Treating Participants With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant" @default.
- Q66067477 P1050 Q66067477-47BBA658-DF57-452C-AFCC-F3B1399D0DAD @default.
- Q66067477 P1132 Q66067477-66E72D2B-997C-448C-89C4-BF003C4066BB @default.
- Q66067477 P1476 Q66067477-D96378DD-555F-4058-B18F-0CB8D1E42AC0 @default.
- Q66067477 P17 Q66067477-2853E61A-C27B-4284-A930-C9213B6DA6B3 @default.
- Q66067477 P2899 Q66067477-28BB3A8F-2E64-44C4-967A-84E1EF96C05C @default.
- Q66067477 P3098 Q66067477-9B54F79B-1039-45E1-8CDF-5D6CAF87C1B7 @default.
- Q66067477 P31 Q66067477-B8CD6465-4CC1-446A-931C-5DC90462B4B4 @default.
- Q66067477 P4135 Q66067477-A3FE7A3E-1691-45A5-9C68-E47FEC877040 @default.
- Q66067477 P4844 Q66067477-413A2C20-7B35-4E2E-89F2-39BB72E639E1 @default.
- Q66067477 P4844 Q66067477-4E1BBC6D-7A4E-42B7-91C2-CFD3BC6C7326 @default.
- Q66067477 P4844 Q66067477-732D2BBF-AD21-4FBD-9904-48D0DD9F5E55 @default.
- Q66067477 P4844 Q66067477-87BE7B2C-B5F9-4344-BFD4-E79E458B462A @default.
- Q66067477 P4844 Q66067477-AA26AE18-E5FB-4157-9742-47B9ABFF7D11 @default.
- Q66067477 P580 Q66067477-7B59432B-4A49-4EBE-A414-BFCFA043E89E @default.
- Q66067477 P582 Q66067477-D6C1A6FD-F61D-43C2-81C2-3A641B3F18FE @default.
- Q66067477 P6099 Q66067477-C71D01AB-9E47-4B1F-BD51-A7E793EC68ED @default.
- Q66067477 P8363 Q66067477-C7CDF5A1-F282-47FB-B1DC-769DB5C13814 @default.
- Q66067477 P1050 Q208414 @default.
- Q66067477 P1132 "+30" @default.
- Q66067477 P1476 "Olaparib Combined With High-Dose Chemotherapy for Refractory Lymphomas" @default.
- Q66067477 P17 Q30 @default.
- Q66067477 P2899 "+18" @default.
- Q66067477 P3098 "NCT03259503" @default.
- Q66067477 P31 Q30612 @default.
- Q66067477 P4135 "+65" @default.
- Q66067477 P4844 Q2298283 @default.
- Q66067477 P4844 Q412323 @default.
- Q66067477 P4844 Q418011 @default.
- Q66067477 P4844 Q50429626 @default.
- Q66067477 P4844 Q905901 @default.
- Q66067477 P580 "2019-06-15T00:00:00Z" @default.
- Q66067477 P582 "2023-07-01T00:00:00Z" @default.
- Q66067477 P6099 Q5452194 @default.
- Q66067477 P8363 Q78089383 @default.